EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 0.0223
December 31, 2025 -0.8477
September 30, 2025 -0.8758
June 30, 2025 -1.021
March 31, 2025 -0.8422
December 31, 2024 -0.5947
September 30, 2024 -0.7325
June 30, 2024 -0.2969
March 31, 2024 -1.027
December 31, 2023 0.4927
September 30, 2023 -4.985
June 30, 2023 -2.716
March 31, 2023 -4.120
December 31, 2022 1.641
September 30, 2022 0.3188
Date Value
June 30, 2022 3.161
March 31, 2022 -4.821
December 31, 2021 -0.3254
September 30, 2021 4.041
June 30, 2021 -26.87
March 31, 2021 -33.99
December 31, 2020 2.121
September 30, 2020 -25.15
June 30, 2020 -0.0399
March 31, 2020 1.772
December 31, 2019 1.147
September 30, 2019 0.312
June 30, 2019 0.1837
March 31, 2019 0.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -0.35
Exicure, Inc. -0.1759
Century Therapeutics, Inc. -0.1679
Absci Corp. -0.2109
Cardio Diagnostics Holdings, Inc. -0.5073